ClinicalTrials.govpublic full text
Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose
ulcerative colitis (uc), ulcerative colitis, upadacitinib, re-induction, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 992248
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.